Log In
Print this Print this


Also known as: ASN-100

  Manage Alerts
Collapse Summary General Information
Company Arsanis Inc.
DescriptionCombination of 2 undisclosed mAbs that neutralize 6 Staphylococcus aureus toxins
Molecular Target
Mechanism of ActionAntibody
Therapeutic ModalityBiologic: Antibody
Latest Stage of DevelopmentPhase I
Standard IndicationStaphylococcus
Indication DetailsPrevent and treat severe Staphylococcus aureus infections
Regulatory Designation
PartnerAdimab LLC

 Product Details
 Archive Items are loading loading
Collapse Summary Deals Information
 Deals Details
Get a free BioCentury trial today